{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:27:29Z","timestamp":1783664849222,"version":"3.55.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p><jats:italic>Streptococcus pneumoniae<\/jats:italic> is a Gram-positive bacterium and the leading cause of bacterial pneumonia in children and the elderly worldwide. Currently, two types of licensed vaccines are available to prevent the disease caused by this pathogen: the 23-valent pneumococcal polysaccharide-based vaccine and the 7-, 10, 13, 15 and 20-valent pneumococcal conjugate vaccine. However, these vaccines, composed of the principal capsular polysaccharide of leading serotypes of this bacterium, have some problems, such as high production costs and serotype-dependent effectiveness. These drawbacks have stimulated research initiatives into non-capsular-based vaccines in search of a universal vaccine against <jats:italic>S. pneumoniae.<\/jats:italic> In the last decades, several research groups have been developing various new vaccines against this bacterium based on recombinant proteins, live attenuated bacterium, inactivated whole-cell vaccines, and other newer platforms. Here, we review and discuss the status of non-capsular vaccines against <jats:italic>S. pneumoniae<\/jats:italic> and the future of these alternatives in a post-pandemic scenario.<\/jats:p>","DOI":"10.3389\/fcimb.2022.949469","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T06:30:53Z","timestamp":1664173853000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection"],"prefix":"10.3389","volume":"12","author":[{"given":"Pedro H.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaneisi","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Campusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angello","family":"Retamal-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita K.","family":"Lay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1128\/IAI.69.2.949-958.2001","article-title":"Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis","volume":"69","author":"Adamou","year":"2001","journal-title":"Infect. Immun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","article-title":"Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial","volume":"390","author":"Alberer","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1128\/IAI.69.6.3569-3575.2001","article-title":"Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia","volume":"69","author":"Alcantara","year":"2001","journal-title":"Infect. Immun."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000304","article-title":"A potential vaccine for prevention streptococcus pneumoniae infection","volume":"6","author":"Alexander","year":"2015","journal-title":"J. Vaccines Vaccin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1128\/iai.62.12.5683-5688.1994","article-title":"Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of streptococcus pneumoniae","volume":"62","author":"Alexander","year":"1994","journal-title":"Infect. Immun."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020187","article-title":"Disruption of the cpse and enda genes attenuates streptococcus pneumoniae virulence: towards the development of a live attenuated vaccine candidate","volume":"8","author":"Amonov","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.meegid.2014.11.007","article-title":"Mechanisms of genome evolution of streptococcus","volume":"33","author":"Andam","year":"2015","journal-title":"Infect Genet. Evol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.1016\/j.vaccine.2020.04.050","article-title":"Immunization with PhtD truncated fragments reduces nasopharyngeal colonization by streptococcus pneumoniae","volume":"38","author":"Andr\u00e9","year":"2020","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","article-title":"Pneumococcal vaccination strategies: An update and perspective","volume":"13","author":"Berical","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1016\/j.vaccine.2012.10.076","article-title":"Safety and immunogenicity of pneumococcal protein vaccine candidates: Monovalent choline-binding protein a (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein d vaccine","volume":"30","author":"Bologa","year":"2012","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1128\/IAI.68.2.796-800.2000","article-title":"Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of streptococcus pneumoniae","volume":"68","author":"Briles","year":"2000","journal-title":"Infect. Immun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/iai.60.1.111-116.1992","article-title":"Strong association between capsular type and virulence for mice among human isolates of streptococcus pneumoniae","volume":"60","author":"Briles","year":"1992","journal-title":"Infect. Immun."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01366","article-title":"Streptococcus pneumoniae\u2019s virulence and host immunity: Aging, diagnostics, and prevention","volume":"9","author":"Brooks","year":"2018","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030168","article-title":"Vaccine escape recombinants emerge after pneumococcal vaccination in the united states","volume":"3","author":"Brueggemann","year":"2007","journal-title":"PloS Pathog."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7494","DOI":"10.1016\/j.vaccine.2021.10.032","article-title":"A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults \u226565 years of age with different prior pneumococcal vaccination","volume":"39","author":"Cannon","year":"2021","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1016\/j.vaccine.2022.05.079","article-title":"Phase 1\/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years","volume":"40","author":"Chichili","year":"2022","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1016\/j.vaccine.2016.11.001","article-title":"Immunization with LytB protein of streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis","volume":"34","author":"Corsini","year":"2016","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5863\/1551-6776-21.1.27","article-title":"A review of pneumococcal vaccines: Current polysaccharide vaccine recommendations and future protein antigens","volume":"21","author":"Daniels","year":"2016","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00118-17","article-title":"Conjugation of PspA4Pro with capsular streptococcus pneumoniae polysaccharide serotype 14 does not reduce the induction of cross-reactive antibodies","volume":"24","author":"da Silva","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e3778","DOI":"10.1093\/cid\/ciaa1483","article-title":"Nationwide trends of invasive pneumococcal disease in Spain from 2009 through 2019 in children and adults during the pneumococcal conjugate vaccine era","volume":"73","author":"de Miguel","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.1016\/j.vaccine.2017.10.076","article-title":"Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: A phase 1 randomised clinical trial","volume":"35","author":"Entwisle","year":"2017","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1001\/archinte.1994.00420230051007","article-title":"Efficacy of pneumococcal vaccination in adults: A meta-analysis of randomized controlled trials","volume":"154","author":"Fine","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00937-20","article-title":"A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus","volume":"11","author":"Ganaie","year":"2020","journal-title":"mBio"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115447","article-title":"Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011\u20132018","volume":"101","author":"Golden","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a010215","article-title":"The pneumococcus: Epidemiology, microbiology, and pathogenesis","volume":"3","author":"Henriques-Normark","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1016\/j.vaccine.2018.05.122","article-title":"Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with streptococcus pneumoniae","volume":"36","author":"Hill","year":"2018","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1056\/nejm199409083311004","article-title":"An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail","volume":"331","author":"Hoge","year":"1994","journal-title":"New Engl. J. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"IAI.00881","DOI":"10.1128\/IAI.00881-09","article-title":"The streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms","volume":"78","author":"Hyams","year":"2010","journal-title":"Infect. Immun."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01212","article-title":"Serotype-independent protection against invasive pneumococcal infections conferred by live vaccine with LGT deletion","volume":"10","author":"Jang","year":"2019","journal-title":"Front. Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/mi.2013.41","article-title":"Pneumococcal IgA1 protease subverts specific protection by human IgA1","volume":"7","author":"Janoff","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1128\/JB.00724-09","article-title":"Pneumococcal LytR, a protein from the LytR-CpsA-Psr family, is essential for normal septum formation in streptococcus pneumoniae","volume":"191","author":"Johnsborg","year":"2009","journal-title":"J. Bacteriol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12275-018-8347-1","article-title":"Gamma-irradiation of streptococcus pneumoniae for the use as an immunogenic whole cell vaccine","volume":"56","author":"Jwa","year":"2018","journal-title":"J. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jiph.2020.04.012","article-title":"High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive\/colonization isolates of streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan","volume":"13","author":"Kawaguchiya","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/INF.0000000000002567","article-title":"A phase 1 randomized, placebo-controlled, observer-blinded trial to evaluate the safety and immunogenicity of inactivated streptococcus pneumoniae whole-cell vaccine in adults","volume":"39","author":"Keech","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.vaccine.2012.02.023","article-title":"Vaccine candidates PhtD and PhtE of streptococcus pneumoniae are adhesins that elicit functional antibodies in humans","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s12272-017-0933-y","article-title":"Pneumonia and streptococcus pneumoniae vaccine","volume":"40","author":"Kim","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.vaccine.2018.12.004","article-title":"Impact and cost effectiveness of pneumococcal conjugate vaccine in India","volume":"37","author":"Krishnamoorthy","year":"2019","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"s41598-020","DOI":"10.1038\/s41598-020-75691-5","article-title":"Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency","volume":"10","author":"L\u00f8chen","year":"2020","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206661","article-title":"Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to streptococcus pneumoniae infection","volume":"13","author":"Lai\u00f1o","year":"2018","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3345\/kjp.2014.57.2.55","article-title":"Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines","volume":"57","author":"Lee","year":"2014","journal-title":"Korean J. Pediatr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00006454-198601000-00008","article-title":"Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children","volume":"5","author":"Leinonen","year":"1986","journal-title":"Pediatr. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1016\/j.vaccine.2014.02.052","article-title":"Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I\/II randomized clinical study","volume":"32","author":"Leroux-Roels","year":"2014","journal-title":"Vaccine"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12941-020-00410-x","article-title":"Molecular epidemiology of streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China","volume":"20","author":"Liang","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B47","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/08820139.2015.1037956","article-title":"Protective immune responses elicited by fusion protein containing PsaA and PspA fragments","volume":"44","author":"Lu","year":"2015","journal-title":"Immunol. Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antibiotics5020021","article-title":"Choline binding proteins from streptococcus pneumoniae: A dual role as enzybiotics and targets for the design of new antimicrobials","volume":"5","author":"Maestro","year":"2016","journal-title":"Antibiotics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1099\/jmm.0.001103","article-title":"Evaluation of protective immunity responses against pneumococcal PhtD and its c-terminal in combination with outer-membrane vesicles as adjuvants","volume":"69","author":"Malekan","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: Updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab576","article-title":"If not now, when? nonserotype pneumococcal protein vaccines","volume":"8","author":"Mcdaniel","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.vaccine.2015.04.025","article-title":"Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults","volume":"33","author":"McFetridge","year":"2015","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1469-0691.2010.03183.x","article-title":"Streptococcus pneumoniae: Virulence factors and variation","volume":"16","author":"Mitchell","year":"2010","journal-title":"Clin. Microbiol. Infect"},{"key":"B54","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1128\/IAI.01475-06","article-title":"Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance","volume":"75","author":"Nelson","year":"2007","journal-title":"Infect. Immun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1566523211313010006","article-title":"Gene elements that regulate streptococcus pneumoniae virulence and immunity evasion","volume":"13","author":"Nieto","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00006454-199605000-00009","article-title":"Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines","volume":"15","author":"O\u2019Brien","year":"1996","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/j.vaccine.2017.03.071","article-title":"Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study","volume":"35","author":"Odutola","year":"2017","journal-title":"Vaccine"},{"key":"B60","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/21645515.2015.1111496","article-title":"Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2\u20134 years: A phase II randomized study","volume":"12","author":"Odutola","year":"2016","journal-title":"Hum. Vaccin Immunother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1128\/IAI.01103-06","article-title":"Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of streptococcus pneumoniae","volume":"75","author":"Ogunniyi","year":"2007","journal-title":"Infect. Immun."},{"key":"B62","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(13)70332-3","article-title":"Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: An observational study","volume":"14","author":"Okike","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1093\/cid\/cix115","article-title":"Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era","volume":"64","author":"Olarte","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1473-3099(20)30165-1","article-title":"Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study","volume":"21","author":"Ouldali","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10517-020-04736-6","article-title":"Immunization with recombinant pneumolysin induces the production of antibodies and protects mice in a model of systemic infection caused by streptococcus pneumoniae","volume":"168","author":"Petukhova","year":"2020","journal-title":"Bull. Exp. Biol. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J. Infect. Dis."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00329-21","article-title":"New pneumococcal serotype 15D","volume":"59","author":"Pimenta","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/srep22972","article-title":"Pneumococcal pneumolysin induces DNA damage and cell cycle arrest","volume":"6","author":"Rai","year":"2016","journal-title":"Sci. Rep."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00358","article-title":"Mechanisms of naturally acquired immunity to streptococcus pneumoniae","volume":"10","author":"Ramos-Sevillano","year":"2019","journal-title":"Front. Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1164\/RCCM.202011-4161LE","article-title":"Preclinical development of virulence-attenuated streptococcus pneumoniae strains able to enhance protective immunity against pneumococcal infection","volume":"203","author":"Ramos-Sevillano","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030261","article-title":"Protective effect of nasal colonisation with \u0394cps\/piaa and \u0394cps\/proabc streptococcus pneumoniae strains against recolonisation and invasive infection","volume":"9","author":"Ramos-Sevillano","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01963","article-title":"New vaccine technologies to combat outbreak situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front. Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1128\/IAI.71.1.75-85.2003","article-title":"Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of streptococcus pneumoniae","volume":"71","author":"Ren","year":"2003","journal-title":"Infect. Immun."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105092","article-title":"Development of a pneumococcal conjugate vaccine based on chemical conjugation of polysaccharide serotype 6B to PspA","volume":"158","author":"Santiesteban-Lores","year":"2021","journal-title":"Microb. Pathog."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00309","article-title":"Clinical relevance and molecular pathogenesis of the emerging serotypes 22F and 33F of streptococcus pneumoniae in Spain","volume":"11","author":"Sempere","year":"2020","journal-title":"Front. Microbiol."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020181","article-title":"Pneumococcal choline-binding proteins involved in virulence as vaccine candidates","volume":"9","author":"Sempere","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1128\/IAI.00422-16","article-title":"Influenza a virus infection predisposes hosts to secondary infection with different streptococcus pneumoniae serotypes with similar outcome but serotype-specific manifestation","volume":"84","author":"Sharma-Chawla","year":"2016","journal-title":"Infect. Immun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"B79","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/21645515.2018.1532249","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults","volume":"15","author":"Stacey","year":"2019","journal-title":"Hum. Vaccin Immunother."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000304","article-title":"Chimeric protein pspf, a potential vaccine for prevention streptococcus pneumoniae infection","volume":"6","author":"Suvorov","year":"2015","journal-title":"J Vaccines Vaccination"},{"key":"B81","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect"},{"key":"B82","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.1061217","article-title":"Complete genome sequence of a virulent isolate of Streptococcus pneumoniae","volume":"293","author":"Tettelin","year":"2001","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.vaccine.2020.04.064","article-title":"Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid","volume":"39","author":"Thanawastien","year":"2021","journal-title":"Vaccine"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1016\/j.vaccine.2019.08.048","article-title":"Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults","volume":"37","author":"Thompson","year":"2019","journal-title":"Vaccine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2005.02.033","article-title":"Structural basis of pore formation by the bacterial toxin pneumolysin","volume":"121","author":"Tilley","year":"2005","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","volume":"10","author":"van der Pol","year":"2015","journal-title":"Biotechnol. J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of streptococcus pneumoniae and haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"B89","doi-asserted-by":"publisher","first-page":"7858","DOI":"10.1016\/j.vaccine.2020.10.005","article-title":"Serotype distribution of streptococcus pneumoniae isolated from children hospitalized in Beijing children\u2019s hospital 2013\u20132019)","volume":"38","author":"Wang","year":"2020","journal-title":"Vaccine"},{"key":"B90","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: Transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: Transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1128\/IAI.72.11.6324-6329.2004","article-title":"RNA Encoding the MPT83 antigen induces protective immune responses against mycobacterium tuberculosis infection","volume":"72","author":"Xue","year":"2004","journal-title":"Infect. Immun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12275-014-3583-5","article-title":"Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1","volume":"52","author":"Xu","year":"2014","journal-title":"J. Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.chom.2016.12.005","article-title":"Host-to-Host transmission of streptococcus pneumoniae is driven by its inflammatory toxin, pneumolysin","volume":"21","author":"Zafar","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B95","doi-asserted-by":"publisher","first-page":"13564","DOI":"10.1073\/pnas.1307228110","article-title":"Multiple antigen-presenting system (MAPS) to induce comprehensive b-and T-cell immunity","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1128\/IAI.69.6.3827-3836.2001","article-title":"Recombinant PhpA protein, a unique histidine motif-containing protein from streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge","volume":"69","author":"Zhang","year":"2001","journal-title":"Infect. Immun."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00258","article-title":"Epidemiology characteristics of streptococcus pneumoniae from children with pneumonia in shanghai: A retrospective study","volume":"9","author":"Zhao","year":"2019","journal-title":"Front. Cell Infect. Microbiol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.949469\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T06:30:55Z","timestamp":1664173855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.949469\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":97,"alternative-id":["10.3389\/fcimb.2022.949469"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.949469","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"article-number":"949469"}}